A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT05672576. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Adult Subjects With Moderate-to-severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to severe symptoms. The main questions it aims to answer are: * How well cenerimod works on top of the treatment already being administered. * How safe cenerimod is for adult patients with Systemic Lupus Erythematosus. Researchers will compare one dose of cenerimod and a placebo to see how well cenerimod works when it is added to the treatment already being administered. In this research study approximately 210 participants will receive cenerimod and approximately 210 participants will receive placebo for 12 months.
Study identification
- NCT ID
- NCT05672576
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 451 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 26, 2023 (Actual)
- Primary completion
- Dec 31, 2026 (Estimated)
- Completion
- Jun 30, 2027 (Estimated)
- Last update posted
- Sep 15, 2026
2023 – 2027
United States locations
- U.S. sites
- 17
- U.S. states
- 7
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tucson Clinical Research Institute, LLC | Tucson | Arizona | 85712 | — |
| UCSD Perlman Medical Offices | La Jolla | California | 92037-0943 | — |
| Amicis Research Center | Northridge | California | 91234 | — |
| Hope Clinical Trials, Inc. | Coral Gables | Florida | 33134 | — |
| Vital Pharma Research | Hialeah | Florida | 33016 | — |
| Tectum Medical Research | Hollywood | Florida | 33024 | — |
| Alloy Clinical Research, LLC | Kissimmee | Florida | 34741 | — |
| Allied Biomedical Research Institute | Miami | Florida | 33155 | — |
| D&H National Research Centers INC | Miami | Florida | 33155 | — |
| Professional research Center INC | Miami | Florida | 33172 | — |
| San Marcus Research Clinic, Inc. | Miami Lakes | Florida | 33014 | — |
| Tandem Clinical Research | Marrero | Louisiana | 70072 | — |
| RB Wellness Clinic | Las Vegas | Nevada | 89102 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Precision Comprehensive Clinical Research Solutions | Colleyville | Texas | 76034 | — |
| Texas Arthritis Center | El Paso | Texas | 79902 | — |
| Northwest Houston Arthritis Center | Houston | Texas | 77090 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 130 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05672576, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05672576 live on ClinicalTrials.gov.